![Frederick M. Miesowicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick M. Miesowicz
No open positions remaining
Profile
Dr. Frederick M.
Miesowicz is Chief Operating Officer & VP-Manufacturing at Argos Therapeutics, Inc.
Dr. Miesowicz was previously employed as Vice President-US Operations by Gamida Cell Ltd., Senior Vice President & General Manager by Hybridon Specialty Products, Vice President & General Manager by Cellcor, Inc., a Principal by Terumo Medical Corp., and Vice President by Dupont de Nemours.
He received his undergraduate degree from Siena College and a doctorate degree from Harvard University.
Former positions of Frederick M. Miesowicz
| Companies | Position | End |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Chief Operating Officer | 2016-04-21 |
| GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Hybridon Specialty Products | Corporate Officer/Principal | 1999-12-31 |
Cellcor, Inc.
 Cellcor, Inc. Miscellaneous Commercial ServicesCommercial Services Development of cellular therapies | Corporate Officer/Principal | 1997-12-31 |
DuPont de Nemours (Luxembourg) SARL
 DuPont de Nemours (Luxembourg) SARL Chemicals: SpecialtyProcess Industries Manufactures synthetic resins, synthetic rubbers and industrial chemicals | Corporate Officer/Principal | - |
Training of Frederick M. Miesowicz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Hybridon Specialty Products | |
Cellcor, Inc.
Cellcor, Inc. Miscellaneous Commercial ServicesCommercial Services Development of cellular therapies | Commercial Services |
Siena College
 Siena College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terumo Medical Corp.
 Terumo Medical Corp. Medical SpecialtiesHealth Technology Manufactures and distributes medical products | Health Technology |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
DuPont de Nemours (Luxembourg) SARL
DuPont de Nemours (Luxembourg) SARL Chemicals: SpecialtyProcess Industries Manufactures synthetic resins, synthetic rubbers and industrial chemicals | Process Industries |
- Stock Market
- Insiders
- Frederick M. Miesowicz
